Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

NCT00703781 ·Status: COMPLETED ·Phase: PHASE3

Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery

NCT01847638 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

NCT00704418 ·Status: COMPLETED ·Phase: PHASE3

Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

NCT00333918 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

NCT01367249 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

NCT00791323 ·Status: COMPLETED ·Phase: PHASE4

Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

NCT01475877 ·Status: COMPLETED

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

NCT00377546 ·Status: COMPLETED ·Phase: PHASE4

Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase

NCT00520260 ·Status: COMPLETED ·Phase: PHASE4

NSAIDs and PGE2 Levels in Vitrectomy Patients

NCT02361645 ·Status: COMPLETED ·Phase: PHASE3

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

NCT00348582 ·Status: COMPLETED ·Phase: PHASE4

Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery

NCT00904904 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery

NCT00198445 ·Status: COMPLETED ·Phase: PHASE3

Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial

NCT03886779 ·Status: COMPLETED ·Phase: PHASE4

Effect of Prophylactic Ketorolac on CME After Cataract Surgery

NCT00335439 ·Status: COMPLETED ·Phase: NA

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

NCT00595543 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Bromfenac Ophthalmic Solution

NCT00585975 ·Status: COMPLETED ·Phase: PHASE2

Prophylactic Ketorolac Post Epiretinal Membrane Surgery

NCT00974753 ·Status: COMPLETED ·Phase: NA

Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery

NCT01395069 ·Status: COMPLETED ·Phase: PHASE4

Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%

NCT06539637 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Topical Bromfenac for Intraoperative Miosis and Pain Reduction

NCT03831984 ·Status: UNKNOWN ·Phase: PHASE4

Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery

NCT00645671 ·Status: COMPLETED ·Phase: PHASE3

Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo

NCT00405730 ·Status: COMPLETED ·Phase: PHASE3

Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care

NCT00698724 ·Status: COMPLETED ·Phase: PHASE4

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

NCT00699153 ·Status: COMPLETED ·Phase: PHASE3